Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kazunori Uegaki"'
Autor:
Wakae Kawaguchi, Hiroaki Itamochi, Jun Naniwa, Tetsuro Oishi, Junzo Kigawa, Akiko Kudoh, Michiko Nonaka, Seiya Sato, Kazunori Uegaki, Naoki Terakawa, Shinya Sato, Muneaki Shimada, Tasuku Harada
Publikováno v:
International Journal of Gynecologic Cancer. 22:922-929
ObjectiveThis study was aimed to elucidate the roles of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3′-kinase (PI3K)/Akt pathways in regulating cytotoxicity induced by cispl
Autor:
Tetsuro Oishi, Michiko Nonaka, Kazunori Uegaki, Junzo Kigawa, Hiroaki Itamochi, Jun Naniwa, Naoki Terakawa, Muneaki Shimada, Shinya Sato, Seiya Sato
Publikováno v:
Cancer Science. 100:546-551
Resistance of ovarian mucinous adenocarcinoma to standard chemotherapy with paclitaxel and carboplatin is associated with poor prognosis, and an effective treatment is needed. The present study aimed to identify an effective chemotherapy for ovarian
Autor:
Muneaki Shimada, Wakae Kawaguchi, Hiroaki Itamochi, Kazunori Uegaki, Tetsuro Oishi, Yasunobu Kanamori, Masakuni Takahashi, Naoki Terakawa, Junzo Kigawa, Ruri Kaneko, Jun Naniwa
Publikováno v:
Cell and Tissue Research. 323:523-528
PTEN is involved in the regulation of normal cellular functions in addition to its well-known role as a tumor suppressor. In the present study, we have shown that stable transfection of the PTEN gene into PTEN-mutated endometrial carcinoma cells lead
Autor:
Yasunobu Kanamori, Muneaki Simada, Naoki Terakawa, Hiroaki Itamochi, Takahiro Iba, Kazunori Uegaki, Tetsuro Oishi, Jun Naniwa, Junzo Kigawa
Publikováno v:
Cancer Science. 95:418-423
The present study was conducted to determine whether and how expression of the c-myc gene is related to the response to chemotherapy in patients with epithelial ovarian cancer. This study includes 101 consecutive patients with stage Ic to IV epitheli
Autor:
Imari Deura, Junzo Kigawa, Tetsuro Oishi, Tasuku Harada, Kazunori Uegaki, Seiya Sato, Hiroaki Itamochi, Muneaki Shimada, Jun Naniwa, Shinya Sato
Publikováno v:
International journal of clinical oncology. 19(2)
We performed a retrospective study to clarify the outcome of stage IB2–IIB patients with bulky cervical cancer who underwent neoadjuvant chemotherapy (NAC) followed by radical hysterectomy and adjuvant treatment. Sixty-five patients with bulky stag
Autor:
Muneaki Shimada, Jun Naniwa, Tetsuro Oishi, Tasuku Harada, Shinya Sato, Junzo Kigawa, Naoki Terakawa, Hiroaki Itamochi, Michiko Nonaka, Kazunori Uegaki, Seiya Sato
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 17(14)
Purpose: The mTOR pathway is thought to be a central regulator of proliferation and survival of cells. Rapamycin and its analogs are undergoing clinical trials in patients with epithelial ovarian cancer. This study aimed to assess the potential to us
Autor:
Toshihide Ogawa, Michiko Nonaka, Hiroaki Itamochi, Shinya Sato, Shinya Fujii, Junzo Kigawa, Seiya Sato, Kazunori Uegaki, Jun Naniwa, Muneaki Shimada
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 19(5)
Objective: Preoperative and intraoperative assessments of myometrial invasion (MI) are commonly used for planning surgical procedures such as dissection of the para-aortic node; however, the assessments often differ from the final diagnosis determine
Autor:
Muneaki Shimada, Naoki Terakawa, Hiroaki Itamochi, Masakuni Takahashi, Tetsuro Oishi, Junzo Kigawa, Kazunori Uegaki, Yasunobu Kanamori, Wakae Kawaguchi, Ruri Kaneko, Jun Naniwa
Publikováno v:
Oncology reports. 14(2)
PTEN and the PI3K/Akt pathway are involved in the development and/or progression of endometrial carcinoma. To clarify the impact of the pathway-related molecules on prognosis, we analyzed PTEN, phosphorylated-Akt (p-Akt), and Ki-67 expression by immu
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 62
Autor:
Muneaki Shimada, Kazunori Uegaki, Jun Naniwa, Naoki Terakawa, Tetsuro Oishi, Shinya Sato, Yasunobu Kanamori, Hiroaki Itamochi, Takahiro Iba, Junzo Kigawa
Publikováno v:
Cancer chemotherapy and pharmacology. 53(3)
The aim of this study was to determine the behavior of docetaxel (DTX) in ovarian cancer cells resistant to paclitaxel (PTX).We used human ovarian adenocarcinoma cell lines KF, KFTx (PTX-resistant KF), SK-OV-3, and HAC-2. The sensitivity of the cells